JSAM
ZBH icon

J. Safra Asset Management’s Zimmer Biomet ZBH Stock Holding History

J. Safra Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-268
Closed -$35.4K – 282
2024
Q1 		$35.4K Buy
268
+235
+712% +$29.4K ﹤0.01% 107
2023
Q4 		$4.02K Buy
+33
New +$3.68K ﹤0.01% 114

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

J. Safra Asset Management's ZBH Position: Q2 2024 in Review

J. Safra Asset Management sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 268 shares — an estimated $35.4K sold.

J. Safra Asset Management first reported a position in ZBH in Q4 2023 and held it in 2 quarters. The position peaked at $35.4K in Q1 2024. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • J. Safra Asset Management reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • J. Safra Asset Management sold 268 Zimmer Biomet shares in Q2 2024, an estimated $35.4K.
  • J. Safra Asset Management first reported a position in Zimmer Biomet in Q4 2023 and held it in 2 quarters.
  • J. Safra Asset Management's Zimmer Biomet position peaked at $35.4K in Q1 2024.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on J. Safra Asset Management's 13F filing for Q2 2024, filed 17 Jul 2024.